Director/PDMR Share Dealings

Director/PDMR Share Dealings


Calendar
April 1, 2014

Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that it was notified on March 31, 2014 that on that day Ordinary Shares (“Shares”) and American Depository Shares (“ADSs”) of the Company, as set out below, had been awarded under the Shire Executive Annual Incentive Plan (“EAIP”) to Persons Discharging Managerial Responsibility (“PDMRs”). The Shares and ADSs were acquired on March 31, 2014 at prices of £29.8997 per Share and $147.64 per ADS. 

 Type of Security Number of Securities 
Flemming Ornskov ADSs 2,703 
Tatjana May Shares 4,176 

 

The awards will normally be released to participants after a period of three years.  One ADS is equal to three Shares.

In addition, the Company was notified on March 31, 2014 of the release of the following Shares awarded in 2011 under the EAIP.

 Number of Shares Released Number of Shares sold to satisfy tax liabilities 
Tatjana May 4,517 2,139 

 

On March 31, 2014 sufficient Shares were sold to satisfy tax liabilities as set out above. The Shares were sold at a price of £29.8076 per Share.

The above transactions in Shares and ADSs took place on the London Stock Exchange and NASDAQ respectively.

This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.

Tony Guthrie

Deputy Company Secretary

 

For further information please contact:

Investor Relations
Laurie Stelzer
[email protected]
+1 781 482 0733

Eric Rojas
[email protected]
+1 781 482 0999

Sarah Elton-Farr
[email protected]
+44 1256 894157

Notes to editors

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.

www.shire.com

Click here for the PDF version of this press release.